Please use this identifier to cite or link to this item: https://doi.org/10.2217/nnm.09.17
DC FieldValue
dc.titleTrastuzumab-functionalized nanoparticles of biodegradable copolymers for targeted delivery of docetaxel
dc.contributor.authorSun, B.
dc.contributor.authorFeng, S.-S.
dc.date.accessioned2014-10-09T07:05:06Z
dc.date.available2014-10-09T07:05:06Z
dc.date.issued2009
dc.identifier.citationSun, B., Feng, S.-S. (2009). Trastuzumab-functionalized nanoparticles of biodegradable copolymers for targeted delivery of docetaxel. Nanomedicine 4 (4) : 431-445. ScholarBank@NUS Repository. https://doi.org/10.2217/nnm.09.17
dc.identifier.issn17435889
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/90423
dc.description.abstractAims: We synthesized a novel system of docetaxel-loaded, tratuzumab-functionalized nanoparticles (NPs) of biodegradable copolymers for targeted and synergistic chemotheraphy. Material & Methods: NPs of two component biodegradable copolymers were prepared by a modified solvent extraction/evaporation method with D-α-tocopheryl polyethylene glycol succinate (TPGS) as emulsifier. One component copolymer is poly(lactide)-TPGS, which is of desire hydrophobic-lipophilic balance for cellular adhesion, and another is carboxyl group-terminated TPGS, which facities the conjugation of trastuzumab on the NP surface for targeting. Results: In vitro investigation with SK-BR-3 breast cancer cell of HER2 overexpression showed that the tratuzumab-functionalized NPs have great advantages over nude NPs in cellular uptake and cytotocity. Conclusion: Trastuzumab conjugated onto the NP surface has two functions: one is to target HER2-overexpressing cancer cells and the other is to enhance the cytotoxicity of docetaxel through synergistic effects. The trastusumab-functionalized, docetaxel-loaded NPs have great potential for targeted chemotheraphy to treat HER2-overexpressing cancer. © 2009 Future Medicine Ltd.
dc.description.urihttp://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.2217/nnm.09.17
dc.sourceScopus
dc.subjectBiodegradable polymers
dc.subjectBiomaterials
dc.subjectCancer nanotechnology
dc.subjectChemotherapeutic engineering
dc.subjectDrug delivery
dc.subjectHerceptin®
dc.subjectNanobiotechnology
dc.typeArticle
dc.contributor.departmentCHEMICAL & BIOMOLECULAR ENGINEERING
dc.description.doi10.2217/nnm.09.17
dc.description.sourcetitleNanomedicine
dc.description.volume4
dc.description.issue4
dc.description.page431-445
dc.identifier.isiut000268005100014
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.